发明授权
- 专利标题： NK1 antagonists
- 专利标题（中）： NK1拮抗剂
-
申请号： US13245403申请日： 2011-09-26
-
公开(公告)号： US08754216B2公开(公告)日： 2014-06-17
- 发明人: Sapna S. Shah , Anandan Palani , Xianhai Huang , Dong Xiao , Sunil Paliwal , Hon-Chung Tsui , Michelle Laci Wrobleski , Ashwin U. Rao , Cheng Wang , Neng-Yang Shih
- 申请人： Sapna S. Shah , Anandan Palani , Xianhai Huang , Dong Xiao , Sunil Paliwal , Hon-Chung Tsui , Michelle Laci Wrobleski , Ashwin U. Rao , Cheng Wang , Neng-Yang Shih
- 申请人地址： US FL Miami
- 专利权人： OPKO Health, Inc.
- 当前专利权人： OPKO Health, Inc.
- 当前专利权人地址： US FL Miami
- 代理机构： Choate, Hall & Stewart LLP
- 代理商 Brenda Herschbach Jarrell; Kristen C. Buteau
- 主分类号： C07F7/02
- IPC分类号： C07F7/02 ; C07D215/12 ; C07D215/16 ; C07D213/02 ; C07D405/00
摘要：
A compound having the general structure shown in Formula I: or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
公开/授权文献
- US20120295879A1 NK1 Antagonists 公开/授权日：2012-11-22
信息查询
